Facultative dosage compensation of developmental genes on autosomes in Drosophila and mouse embryonic stem cells.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30194291.
- Also identified by DOI 10.1038/s41467-018-05642-2 and PMC identifier 6128902.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Haploinsufficiency and aneuploidy are two phenomena, where gene dosage alterations cause severe defects ultimately resulting in developmental failures and disease. One remarkable exception is the X chromosome, where copy number differences between sexes are buffered by dosage compensation systems. In Drosophila, the Male-Specific Lethal complex (MSLc) mediates upregulation of the single male X chromosome. The evolutionary origin and conservation of this process orchestrated by MSL2, the only male-specific protein within the fly MSLc, have remained unclear. Here, we report that MSL2, in addition to regulating the X chromosome, targets autosomal genes involved in patterning and morphogenesis. Precise regulation of these genes by MSL2 is required for proper development. This set of dosage-sensitive genes maintains such regulation during evolution, as MSL2 binds and similarly regulates mouse orthologues via Histone H4 lysine 16 acetylation. We propose that this gene-by-gene dosage compensation mechanism was co-opted during evolution for chromosome-wide regulation of the Drosophila male X.
Medical subject headings
- DNA-Binding Proteins
- Dosage Compensation, Genetic
- Drosophila Proteins
- Embryonic Stem Cells
- Gene Expression Regulation, Developmental
- Genes, Developmental
- Nuclear Proteins
- Transcription Factors